Hematology-oncology specialists at Miami Cancer Institute at Baptist Health South Florida combine advanced knowledge of myeloproliferative diseases and the latest treatment options to provide multidisciplinary, comprehensive care for these complex, rare conditions.
These diseases require a precise diagnosis for proper treatment. Hematopathologists at Miami Cancer Institute are experienced in diagnosing these disorders with a special understanding that is crucial to your care plan.
Myeloproliferative diseases describe a group of rare blood disorders that cause the bone marrow to produce too many blood cells.
The disorder occurs in the bone marrow – the center part of most bones where blood cells are made – but can affect other parts of the body, including the spleen, liver and cardiovascular system.
The several types of myeloproliferative diseases are organized by whether the bone marrow makes too many white blood cells, red blood cells or platelets. In some types, too many of more than one type of blood cell are made.
The most common types of myeloproliferative diseases are:
In some cases, chronic types of myeloproliferative diseases develop into acute leukemia.
Risk factors for myeloproliferative diseases include: